CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System
February 27, 2023Business Services
Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …
Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment
February 27, 2023Business Services
Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …
FDA sued by US states over abortion pill access
February 27, 2023Medical Communications
Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …
Causeway Therapeutics raises £8.75m for tennis elbow research
February 27, 2023Medical Communications
University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …
AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease
February 27, 2023Medical Communications
AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …
Merck to appeal EU rejection of COVID-19 drug
February 27, 2023Medical Communications
Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …
Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents
February 24, 2023Business Services
WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …
Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer
February 24, 2023Business Services
BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for …
Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space
February 24, 2023Business Services
24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches
AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
February 24, 2023Business Services
LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …
Sanofi and Glooko partner on ‘connected insulin’ tech
February 24, 2023Medical Communications
Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …
Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use
February 24, 2023Medical Communications
US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …
NICE approved BMS’s Opdivo for lung cancer
February 24, 2023Medical Communications
Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …
Moda Living and LloydsPharmacy partner to offer residents prescription service
February 24, 2023Medical Communications
Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP. VideoGP will …
UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency
February 23, 2023Business Services
February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …
NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer
February 23, 2023Business Services
(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …
LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN
February 23, 2023Business Services
Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …
Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
February 23, 2023Business Services
Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …
8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline
February 23, 2023Business Services
LONDON 23rd February 2023
BiomX shares positive data from first bacteriophage trial
February 23, 2023Research and Development
BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
